Chief Executive Officer
Thu, Feb 16, 2023
Feb 16
3,022 shares @ $19.57
Decreased holdings by -0.30%
Net across this filing: +0.40% (+5,290 shares)
21st largest trade (out of 185)
Tax Sell-to-CoverPositive 90D History
Trade made by an officer
Automatic sale to cover taxes on a vest — not a discretionary trade
Net holdings across this filing: +0.4% (+5,290 shares)
62% win rate · -0.8% median edge vs SPY (13 trades, 90-day · small sample)
Win rate excludes trades classified as routine (tax, 10b5-1, exercise, gift).
DAWNDay One Biopharmaceuticals, Inc.
HealthcareBiotechnology